Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |